Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain.
Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain.
复制标题
评估抗抑郁治疗辅助加巴喷丁和普瑞巴林治疗 SCI 相关神经性疼痛的有效性。
DOI:
10.1080/10790268.2017.1415246
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Zhang,Jie
中科院分区:
文献类型:
--
作者:
McKinley,EmilyCarol;Richardson,ElizabethJ;McGwin,Gerald;Zhang,Jie
Objective:To investigate if a combination of anticonvulsant and antidepressant, two primary therapies for neuropathic pain, is associated with improved pain control compared to individual therapy.Design:Prospective cohort studySetting:The University of Alabama at Birmingham Rehabilitation Center In-patient Program between 2012 and 2015.Participants:Incident SCI cases, 19–65 years of age.Outcomes:Bryce-Ragnarsson pain classification scheme and the Numerical Rating ScaleResults:Twenty-nine eligible patients completed 6-month follow-up; their average age was 36.4 years, 89% were male, and 65% were white. Baseline characteristics were not different by therapy initiated (combination versus single). At 6 months follow-up, therapy initiated at baseline was not associated with level of pain in the past week (p=0.3145) or past 24 hours (p=0.4107). However, patients who remained on the same therapy reported lower levels of pain 30 minutes after waking (p=0.0235).Conclusions:The initiation of a combination of anticonvulsant and antidepressant shortly after SCI was not associated with improved pain control at 6 months compared to individual therapy. Adherent patients reported lower levels of pain; further analysis is warranted to elucidate this association.